These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 34529791)

  • 1. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Sinha A; Rahman H; Webb A; Shah AM; Perera D
    Eur Heart J; 2021 Nov; 42(43):4431-4441. PubMed ID: 34529791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
    Sinha A; Rahman H; Perera D
    Curr Opin Cardiol; 2023 Nov; 38(6):521-526. PubMed ID: 37668191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF.
    Paolisso P; Gallinoro E; Belmonte M; Bertolone DT; Bermpeis K; De Colle C; Shumkova M; Leone A; Caglioni S; Esposito G; Fabbricatore D; Moya A; Delrue L; Penicka M; De Bruyne B; Barbato E; Bartunek J; Vanderheyden M
    Circ Heart Fail; 2024 Jan; 17(1):e010805. PubMed ID: 38108151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction.
    Chandramouli C; Ting TW; Tromp J; Agarwal A; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Lagerström Fermer M; Gan LM; Lund L; Shah SJ; Lam CSP
    Eur J Heart Fail; 2022 Apr; 24(4):681-684. PubMed ID: 35060248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction.
    Ahmad A; Corban MT; Toya T; Verbrugge FH; Sara JD; Lerman LO; Borlaug BA; Lerman A
    Eur J Heart Fail; 2021 May; 23(5):765-772. PubMed ID: 32949186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study.
    Hage C; Svedlund S; Saraste A; Faxén UL; Benson L; Fermer ML; Gan LM; Shah SJ; Lam CSP; Lund LH
    J Card Fail; 2020 Nov; 26(11):1016-1021. PubMed ID: 32846205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction.
    Wang Y; Zhang J; Wang Z; Wang C; Ma D
    Heart Fail Rev; 2023 Jan; 28(1):169-178. PubMed ID: 35266091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between coronary microvascular dysfunction, atrial fibrillation and heart failure with preserved ejection fraction.
    Ozcan C; Allan T; Besser SA; de la Pena A; Blair J
    Am J Cardiovasc Dis; 2021; 11(1):29-38. PubMed ID: 33815917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of coronary microvascular dysfunction (CMD) in heart failure with preserved ejection fraction (HFpEF): a systematic review and meta-analysis.
    Lin X; Wu G; Wang S; Huang J
    Heart Fail Rev; 2024 Mar; 29(2):405-416. PubMed ID: 37870703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular magnetic resonance assessment of coronary flow reserve improves risk stratification in heart failure with preserved ejection fraction.
    Kato S; Fukui K; Kodama S; Azuma M; Nakayama N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):112. PubMed ID: 34657615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction.
    Erhardsson M; Ljung Faxén U; Venkateshvaran A; Svedlund S; Saraste A; Lagerström Fermer M; Gan LM; Shah SJ; Tromp J; Sp Lam C; Lund LH; Hage C
    ESC Heart Fail; 2023 Dec; 10(6):3729-3734. PubMed ID: 37920127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms.
    Fopiano KA; Jalnapurkar S; Davila AC; Arora V; Bagi Z
    Curr Cardiol Rev; 2022; 18(2):e310821195986. PubMed ID: 34488616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction.
    Tona F; Montisci R; Iop L; Civieri G
    Rev Cardiovasc Med; 2021 Mar; 22(1):97-104. PubMed ID: 33792251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.
    Taqueti VR; Solomon SD; Shah AM; Desai AS; Groarke JD; Osborne MT; Hainer J; Bibbo CF; Dorbala S; Blankstein R; Di Carli MF
    Eur Heart J; 2018 Mar; 39(10):840-849. PubMed ID: 29293969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction.
    Markley R; Del Buono MG; Mihalick V; Pandelidis A; Trankle C; Jordan JH; Decamp K; Winston C; Carbone S; Billingsley H; Barron A; Thomas G; Van Tassell B; Hundley WG; Kellman P; Abbate A
    Int J Cardiovasc Imaging; 2023 Apr; 39(4):811-819. PubMed ID: 36607469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.
    Shah SJ; Lam CSP; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Ljung Faxén U; Fermer ML; Broberg MA; Gan LM; Lund LH
    Eur Heart J; 2018 Oct; 39(37):3439-3450. PubMed ID: 30165580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiology of coronary microvascular dysfunction.
    Crea F; Montone RA
    Vascul Pharmacol; 2023 Dec; 153():107239. PubMed ID: 37898380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of coronary microcirculation in heart failure with preserved ejection fraction: An unceasing odyssey.
    Dimitriadis K; Theofilis P; Koutsopoulos G; Pyrpyris N; Beneki E; Tatakis F; Tsioufis P; Chrysohoou C; Fragkoulis C; Tsioufis K
    Heart Fail Rev; 2025 Jan; 30(1):75-88. PubMed ID: 39358622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.